RMD - Resmed Inc.


255.32
-3.730   -1.461%

Share volume: 863,080
Last Updated: 03-05-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%

$259.05
-3.73
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
77%
Profitability 77%
Dept financing 42%
Liquidity 56%
Performance 91%
Company vs Stock growth
vs
Performance
5 Days
-0.80%
1 Month
-6.00%
3 Months
2.11%
6 Months
-8.64%
1 Year
13.46%
2 Year
38.55%
Key data
Stock price
$255.32
P/E Ratio 
23.66
DAY RANGE
$250.97 - $258.20
EPS 
$10.15
52 WEEK RANGE
$199.92 - $293.81
52 WEEK CHANGE
$9.84
MARKET CAP 
35.159 B
YIELD 
0.94%
SHARES OUTSTANDING 
145.678 M
DIVIDEND
$0.60
EX-DIVIDEND DATE
02-12-2026
NEXT EARNINGS DATE
07-31-2025
BETA 
1.09
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$926,001
AVERAGE 30 VOLUME 
$1,157,252
Company detail
CEO: Michael J. Farrell
Region: US
Website: resmed.com
Employees: 8,160
IPO year: 1995
Issue type: Common Stock
Market: NYSE
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company also provides AirView, a system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools.

Recent news